5-ALA剂量对胶质母细胞瘤切除效果的影响
回顾性队列研究纳入25例新诊断胶质母细胞瘤患者,比较低剂量(10-30 mg/kg,n=6)与高剂量(40-50 mg/kg,n=19)5-ALA荧光引导手术。高剂量组残余肿瘤体积中位数更低、全切可能性更高但无统计学意义,总生存无显著差异。作者认为高剂量与更少残余肿瘤和更高全切概率相关,需更大样本进一步研究。
要点
- 高剂量5-ALA组全切可能性更高,但未达统计学显著。
- 低剂量组残余肿瘤体积中位数0.69 cm3,高剂量组0.00 cm3(p=0.975)。
- 高剂量与低剂量组总生存无显著差异(p=0.6787)。
核心结论
- 高剂量5-ALA荧光引导手术与更少残余肿瘤体积和更高全切概率相关,5-ALA剂量与总生存无关,需更大样本进一步研究。
研究设计与样本
- 回顾性队列研究,分析参与5-ALA切除高级别胶质瘤I期和II期剂量递增临床试验的患者,共25例组织学新诊断胶质母细胞瘤患者纳入。
- 低剂量组为5-ALA 10-30 mg/kg(n=6),高剂量组为40-50 mg/kg(n=19)。
- 术前和术后增强T1加权MRI进行体积分析。
主要发现
- 低剂量组残余肿瘤体积中位数0.69 cm3,高剂量组0.00 cm3(p=0.975)。
- 高剂量组更可能实现全切,但无统计学意义。
- 高剂量组与低剂量组总生存中位数无显著差异(p=0.6787)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文报告需更大样本患者队列进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Fluorescence-guided surgery (FGS) with the use of 5-aminolevulinic acid (5-ALA) leads to more extensive resection of high-grade glioma (HGG) and longer overall survival (OS) of patients compared to conventional resection. The purpose of this study is to investigate the effect of 5-ALA dosages on residual tumor volume (RTV) and OS in patients with glioblastoma. METHODS: A retrospective cohort study for patients who participated in a phase I and II dose-escalation clinical trial on 5-ALA for resection of HGG. A total of 25 patients were found to have newly diagnosed glioblastoma on histology and enrolled in our study. Patients receiving low doses of 5-ALA (10-30 mg/kg) (n = 6) were compared to those receiving high doses (40-50 mg/kg) (n = 19). Pre- and post-operative contrast enhanced T1W MRI were evaluated with volumetric analysis. RESULTS: Median RTV was 0.69 cm3 and 0.00 cm3 in the low and high dose groups respectively (p = 0.975). A gross total resection (GTR) was more likely in the high dose group, though this was not statistically significant. No significant difference was found in median OS between the high and low dose groups (p = 0.6787). CONCLUSIONS: High doses of 5-ALA FGS are associated with less RTV and greater probability of GTR. 5-ALA dose was not associated with OS. Further studies with a larger patient cohort are warranted.
引用
- Michael AP, Watson VL, Ryan D, et al. Effects of 5-ALA dose on resection of glioblastoma. J Neurooncol. 2019. PMID: 30644009. doi:10.1007/s11060-019-03100-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。